The Analyst Landscape: 7 Takes On Kymera Therapeutics
The Analyst Landscape: 7 Takes On Kymera Therapeutics
分析师视角：对kymera therapeutics的7种看法
The standing...In the preceding three months, 7 analysts have released ratings for Kymera Therapeutics (NASDAQ:KYMR), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月里，有7位分析师发布了Kymera Therapeutics（纳斯达克: KYMR）的分析师评级，呈现了从看好到看淡的各种观点。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $50.29, a high estimate of $65.00, and a low estimate of $36.00. Witnessing a positive shift, the current average has risen by 26.36% from the previous average price target of $39.80.
分析师通过对12个月价格目标的评估提供了更深入的见解，显示平均目标为50.29美元，最高估值为65.00美元，最低估值为36.00美元。目前的平均价值已经上涨了26.36%，从之前的39.80美元的平均价格目标。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细剖析
The standing...
通过...
登录免费看全文
登录/注册
资讯热榜
更新时间